NCT06955923View on ClinicalTrials.gov

Trigger Point Injection in Reducing Pain Following Total Knee Arthroplasty

PHASE2RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 30, 2025

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Trigger Point Pain, Myofascial
Interventions
DRUG

Trigger point injection (lidocaine)

A trigger point injection utilizing lidocaine 1% without epinephrine will be injected into several muscles bellies immediately following surgery to halt a trigger point from forming. One group will receive this type of intervention and the sham group will not receive any type of injection.

OTHER

Sham Comparator

This arm of the study will not receive any injection.

Trial Locations (1)

94535

RECRUITING

David Grant Medical Center, Fairfield

All Listed Sponsors
lead

David Grant U.S. Air Force Medical Center

FED

NCT06955923 - Trigger Point Injection in Reducing Pain Following Total Knee Arthroplasty | Biotech Hunter | Biotech Hunter